Modern Diagnostic & Research Centre Limited IPO is fully book build issue and total IPO size is ₹[] crores . The total offering consists of 41 lakhs shares.
The dates for the Modern Diagnostic & Research Centre Limited IPO have not been announced yet. The allotment process is expected to be finalized by [.].
The Modern Diagnostic & Research Centre Limited IPO is scheduled to list on BSE SME, with a listing date of [.]. The price band for the Modern Diagnostic & Research Centre Limited IPO has not been announced yet.
Registrar for this IPO is Mufg Intime India Private Limited and lead managers for Modern Diagnostic & Research Centre Limited IPO are Beeline Capital Advisors Private Limited.
IPO Schedule
| IPO Open Date | - |
|---|---|
| IPO Close Date | - |
| IPO Allotment Date | - |
| Refund Initiation | - |
| Share credit in Demat | - |
| Listing Date | - |
Key Details
| Price Band | TBA |
|---|---|
| Lot Size | TBA |
| Face Value | ₹10.00 Per Equity Share |
| Total Issue Size | 4,100,000 Shares |
| Fresh Issue | 4,100,000 Shares |
| Issue Type | Fresh Issue |
| Listing At | BSE SME |
Share Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB | 50% |
| Retail | 35% |
| NII/HNI | 15% |
About Modern Diagnostic & Research Centre Limited Company
Modern Diagnostic & Research Centre Limited is a leading diagnostic and related healthcare tests service provider in India, offering a comprehensive range of pathology and radiology services. Established in 1985, and formally incorporated in 2012, the company operates 21 centres, including 17 laboratories and 4 diagnostic centres, across 8 states.
With a focus on reliable and quality diagnostic services, Modern Diagnostic offers value-added services like home specimen collection and online report access. The company serves individual patients, hospitals, healthcare providers, and corporate clients. The Indian diagnostic sector is experiencing robust growth, with market revenue reaching INR 981 billion in 2023 and projected to grow to INR 2,204 billion by 2030. Key financial highlights include revenue from operations of INR 67.13 Crore for the year ended March 31, 2024.
Driven by experienced promoters and a dedicated management team, Modern Diagnostic emphasizes customer satisfaction, quality testing, and a centralized IT platform for efficient operations. Their business strategy involves leveraging market skills, providing quality services, expanding geographical presence, and broadening their diagnostic testing platform. The company is dedicated to remaining at the forefront of the diagnostic healthcare sector.
Modern Diagnostic & Research Centre Limited Financial Details
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 577943 | 494857 | 365412 | 486960 |
| Revenue | ||||
| Profit After Tax | ||||
| Net Worth | 167135 | 117582 | 59633 | 116953 |
| Reserves and Surplus | 157135 | 107582 | 49633 | 106953 |
| Total Borrowing | 211317 | 204577 | 153096 | 204005 |
₹ In Crore
Key Performance Indicator
| Basic EPS (in ₹) | Return on Net Worth (RoNW) | Net Asset Value (NAV) | Debt-Equity Ratio | Return on Equity (ROE) | Return on Capital Employed (ROCE) |
|---|---|---|---|---|---|
| 5.27 | 49.28 | 117.58 |
Offer Objectives
The company is planning an IPO of 41,00,000 Equity Shares to fund capital expenditure, working capital, debt repayment, and general corporate purposes.
Regarding promoter contributions, Mr. Devendra Singh Yadav will have 31,20,000 Equity Shares locked in for three years from the date of allotment. This contribution will be at least 20% of the post-issue paid-up capital. Shares forming part of the promoter’s contribution are eligible as per SEBI (ICDR) Regulations, 2018.
Promoter holdings exceeding the minimum contribution will have 50% locked in for two years and the remaining 50% for one year. The entire pre-issue equity share capital held by non-promoters will be locked in for one year.
The net proceeds from the IPO will be used as follows: ₹20.68 crore for purchasing medical equipment, ₹11.59 crore for working capital, ₹4.50 crore for repaying borrowings, and the remaining for general corporate expenses. A significant portion is allocated to establish new diagnostic centers and laboratories with focus on procuring PET CT and SPECT machines in Gurgaon and Bikaner.
The company has signed Letters of Intent (LOIs) for diagnostic center at Bikaner and laboratories at Delhi, Meerut, Kanpur, Lucknow , Chandigarh and Bikaner, indicating progress in expansion plans.
Company Details
Address:
Registered Office: Plot No H -64,1st Floor BLK -H, Bali Nagar City landmark near Khetar Pal Hospital, Ramesh Nagar, West Delhi, New Delhi -110015, India
Phone: 9999474297
Email: [email protected]
Website: http://www.mdrcindia.com
IPO Registrar Details
Mufg Intime India Private Limited
Phone: +91 810 811 4949
Email: [email protected]
Website: https://in.mpms.mufg.com
Offer Prospectus & Documents
Lead Managers
- Beeline Capital Advisors Private Limited
